Preclinical Safety Evaluation of BB106, a Novel Ketamine–Sulfobutylether-Beta-Cyclodextrin Salt, Following Subcutaneous Administration in Rats and Göttingen Minipigs

International Journal of Toxicology · Published 2026-01-20 · DOI 10.1177/10915818251414705

Free full text

Authors being retrieved — see the publisher record. https://doi.org/10.1177/10915818251414705

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Related articles